Εμφανίζονται 1 - 12 Αποτελέσματα από 12 για την αναζήτηση '"МЯГКОЕ КОГНИТИВНОЕ СНИЖЕНИЕ"', χρόνος αναζήτησης: 0,54δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal

    Συνεισφορές: This work was supported by the National Research Center “Kurchatov Institute” (the Thematic Plan for 2023, Order № 86 dated January 20, 2023, "Applied research in biomedicine, including research in primatology")., Работа выполнена при поддержке Национального исследовательского центра "Курчатовский институт" (пункт 1п.4.3 Темплана на 2023 г., приказ № 86 от 20 января 2023 г.).

    Πηγή: Medical Immunology (Russia); Том 25, № 5 (2023); 1233-1240 ; Медицинская иммунология; Том 25, № 5 (2023); 1233-1240 ; 2313-741X ; 1563-0625

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.mimmun.ru/mimmun/article/view/2811/1754; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11804; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11805; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11807; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11808; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11809; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11810; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11811; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11812; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11813; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12296; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12297; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12298; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12299; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12367; Bowman G.L., Dayon L., Kirkland R., Wojcik J., Peyratout G., Severin I.C., Henry H., Oikonomidi A., Migliavacca E., Bacher M., Popp J. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement., 2018, Vol. 14, no. 12, pp. 1640-1650.; Galimberti D., Schoonenboom N., Scheltens P., Fenoglio C., Bouwman F., Venturelli E., Guidi I., Blankenstein M.A., Bresolin N., Scarpini E. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch. Neurol., 2006, Vol. 63, no. 4, pp. 538-543.; Guldner I.H., Wang Q., Yang L., Golomb S.M., Zhao Z., Lopez J.A., Brunory A., Howe E.N., Zhang Y., Palakurthi B., Barron M., Gao H., Xuei X., Liu Y., Li J., Chen D.Z., Landreth G.E., Zhang S. CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10. Cell, 2020, Vol. 183, no. 5, pp. 1234-1248.e25.; Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell, 2012, Vol. 148, no. 6, pp. 1204-1222.; Jang D.I., Lee A.H., Shin H.Y., Song H.R., Park J.H., Kang T.B., Lee S.R., Yang S.H. The Role of Tumor Necrosis Factor Alpha (TNF-a) in autoimmune disease and current TNF-a inhibitors in therapeutics. Int. J. Mol. Sci., 2021, Vol. 22, no. 5, 2719. doi:10.3390/ijms22052719.; Jorda A., Aldasoro M., Aldasoro C., Valles S.L. Inflammatory chemokines expression variations and their receptors in APP/PS1 Mice. J. Alzheimers Dis., 2021, Vol. 83, no. 3, pp. 1051-1060.; Jorda A., Campos-Campos J., Iradi A., Aldasoro M., Aldasoro C., Vila J.M., Valles S.L. The role of chemokines in Alzheimer's Disease. Endocr. Metab. Immune Disord. Drug Targets, 2020, Vol. 20, no. 9, pp. 1383-1390.; Jorda A., Cauli O., Santonja J.M., Aldasoro M., Aldasoro C., Obrador E., Vila J.M., Mauricio M.D., Iradi A., Guerra-Ojeda S., Marchio P., Valles S.L. Changes in chemokines and chemokine receptors expression in a mouse model of Alzheimer's disease. Int. J. Biol. Sci., 2019, Vol. 15, no. 2, pp. 453-463.; Koper O.M., Kaminska J., Sawicki K., Kemona H. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration. Adv. Clin. Exp. Med., 2018, Vol. 27, no. 6, pp. 849-856.; Malashenkova I.K., Krynskiy S.A., Hailov N.A., Ogurtsov D.P., Chekulaeva E.I., Ponomareva E.V., Gavrilova S.I., Didkovsky N.A. Immunological variants of amnestic mild cognitive impairment. S. Korsakov Journal of Neurology and Psychiatry, 2020, Vol. 120, no. 10, pp. 60-68. (In Russ.); Moussa C., Hebron M., Huang X., Ahn J., Rissman R.A., Aisen P.S., Turner R.S. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J. Neuroinflammation, 2017, Vol. 14, no. 1, 1. doi:10.1186/s12974-016-0779-0.; Ramesh G., MacLean A.G., Philipp M.T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm., 2013, Vol. 2013, 480739. doi:10.1155/2013/480739.; Roshchina I.F., Syunyakov T.S., Osipova N.G., Kurmyshev M.V., Savilov V.B., Andruchsenko A.V. Evaluation of the effectiveness of neurocognitive rehabilitation of patients with mild cognitive decline under restrictions during the COVID-19 pandemic. Psychiatry, 2022, Vol. 20, no. 4, pp. 36-43. (In Russ.); Serbina N.V., Shi C., Pamer E.G. Monocyte-mediated immune defense against murine Listeria monocytogenes infection. Adv. Immunol., 2012, Vol. 113, pp. 119-134.; Trollor J.N., Smith E., Baune B.T., Kochan N.A., Campbell L., Samaras K., Crawford J., Brodaty H., Sachdev P. Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement. Geriatr. Cogn. Disord., 2010, Vol. 30, no. 6, pp. 569-578.; https://www.mimmun.ru/mimmun/article/view/2811

  3. 3
    Academic Journal

    Συνεισφορές: 0

    Πηγή: Annals of the Russian academy of medical sciences; Vol 77, No 2 (2022); 107-118 ; Вестник Российской академии медицинских наук; Vol 77, No 2 (2022); 107-118 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn.772

    Περιγραφή αρχείου: application/pdf

  4. 4
  5. 5
    Academic Journal
  6. 6
  7. 7
  8. 8
    Academic Journal

    Πηγή: Ophthalmology in Russia; Том 9, № 4 (2012); 43-46 ; Офтальмология; Том 9, № 4 (2012); 43-46 ; 2500-0845 ; 1816-5095 ; 10.18008/1816-5095-2012-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.ophthalmojournal.com/opht/article/view/174/165; Sperling R. A., Aisen P., et al. Towards defining the preclinical stage of Alzheim- er’s disease: recommendations from the National Institute on Aging and the Al- zheimer’s Association workgroup // Alzheimers Dement. — 2011. — Vol. 7. — P. 160‐167.; Гаврилова С. И., Федорова Я. Б., Рощина И. Ф. и др. Прогноз синдрома мягко- го когнитивного снижения по данным двухлетнего клинико‐катамнестиче- ского исследования // Журнал неврологии и психиатрии. — 2007. — Т. 1. — С. 56‐63.; Blanks J. C., Torigoe Y., et al. Retinal pathology in Alzheimer’s disease. I. Gangli- on cell loss in foveal / parafoveal retina // Neurobiol Aging. — 1996. — Vol. 17, No 3. — P. 377‐384.; Koronyo‐Hamaoui M., Koronyo Y., et al. Identification of amyloid plaques in ret- inas from Alzheimer’s patients and noninvasive in vivo optical imaging of reti- nal plaques in a mouse model // Neuroimage. — 2011. — Vol. 54. — P. 204‐217.; Folstein, M. F., Folstein, S. E, et al. Mini‐Mental State. A practical method for grading the cognitive state of patients for the clinician // J. Psychiatric Res. — 1975. — Vol. 2. — P. 189‐198.; Petersen R. C. Mild cognitive impairment as a useful clinical concept // Geriatric Times. — 2004. — Vol. 5 — P. 1‐5.; Morris J. C. The clinical dementia rating (CDR). Current version and scoring rules // Neurology. — 1993. — Vol. 43. — P. 2412‐2414.; Reisberg B., Ferris S. H., et al. The global deterioration scale (GDS). An instru- ment for the assessment of primary degenerative dementia // Am J. Psychiatry. — 1982. — Vol. 139. — P. 1136‐1139.; Hachinski V. C., Lassen N. A., et al. Multi‐infarct dementia: a cause of mental de- terioration in the elderly // Lancet. — 1974. — Vol. 2. — Р. 207‐210.; Yesavage J. A. Geriatric Depression Scale // Psychopharmacol Bull. — 1988. — Vol. 24. — P. 709‐711.; McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer`s disease: report of the NINCDS‐ADRDA Work Group under the auspices of De- partment of Health and Human Services Task Force on Alzheimer`s disease // Neurology. — 1984. — Vol. 146. — P. 939‐944.; Mirra S. S., Hart M. N., Terry R. D. Making the diagnosis of Alzheimer’s disease: a primer for practicing pathologists // Arch. Pathol. Lab. Med. — 1993. — Vol. 117. — P. 132‐144.; Kesler A., Vakhapova V., et al. Retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease // Clinical Neurology and Neurosurgery. — 2011. — Vol. 113. — P. 523‐526.; Paquet C., Boissonnot M., et al. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease // Neuroscience Letters. — 2007. — Vol. 420. — P. 97‐99.; Kergoat H., Kergoat M. J., et al. Normal optic nerve head topography in the ear- ly stages of dementia of the Alzheimer type // Dementia and Geriatric Cognitive Disorders. — 2001. –Vol. 12. — P. 359‐363.; Tsolaki F, Gogaki E, et al. Alzheimer’s disease and primary open‐angle glauco- ma: is there a connection? // Clin Ophthalmol. — 2011. — Vol. 5. — P. 887‐890.; Iseri P. K., Altinaş O., et al. Relationship between cognitive impairment and ret- inal morphological and visual functional abnormalities in Alzheimer disease // J. Neuro‐Ophthalmology. — 2006. — Vol. 26. — P. 18‐24.; https://www.ophthalmojournal.com/opht/article/view/174

  9. 9
  10. 10
  11. 11
  12. 12